Drug Search Results
More Filters [+]

Monobenzone

Alternative Names: monobenzone, benoquin
Latest Update: None
Latest Update Note: None

Product Description

Monobenzone is the monobenzyl ether of hydroquinone. It is used as a topical drug for medical depigmentation. It has a role as a melanin synthesis inhibitor, a dermatologic drug and an allergen. It derives from a hydroquinone. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Monobenzone)

Mechanisms of Action: tyrosinase Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Approved

Approved Countries: Canada | India | Poland | Portugal | Taiwan | Turkey | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Monobenzone

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title